Biomerica (BMRA) Capital Expenditures Growth (1y) (2011 - 2023)
Biomerica (BMRA) Capital Expenditures Growth (1y) (2011 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.95 Bn | 176.66 Bn | 6.27 Bn | -17.56% |
| 2 | Stryker | 128.83 Bn | 125.95 Bn | 3.81 Bn | 34.96% |
| 3 | Medtronic | 108.81 Bn | 99.59 Bn | 6.41 Bn | 6.32% |
| 4 | Boston Scientific | 68.39 Bn | 66.94 Bn | 3.61 Bn | -5.35% |
| 5 | Edwards Lifesciences | 48.28 Bn | 44.60 Bn | 1.29 Bn | 15.89% |
| 6 | Dexcom | 28.39 Bn | 27.27 Bn | 750.30 Mn | -11.95% |
| 7 | GE HealthCare Technologies | 28.30 Bn | 26.01 Bn | 1.98 Bn | 106.98% |
| 8 | Smith & Nephew | 26.95 Bn | 26.37 Bn | - | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.32 Bn | 2.07 Bn | -47.73% |
| 10 | Biomerica | 4.88 Mn | 3.54 Mn | -44,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Nov 30, 2023 | -75.00% |
| Aug 31, 2023 | -38.24% |
| Feb 28, 2023 | -58.14% |
| Nov 30, 2022 | 83.61% |
| Aug 31, 2022 | 561.35% |
| May 31, 2022 | -15.96% |
| Feb 28, 2022 | -68.28% |
| Nov 30, 2021 | -40.53% |
| Aug 31, 2021 | -87.01% |
| May 31, 2021 | 394.49% |
| Feb 28, 2021 | 111.18% |
| Nov 30, 2020 | 429.34% |
| Aug 31, 2020 | 1,723.49% |
| May 31, 2020 | -79.13% |
| Feb 29, 2020 | 7.72% |
| Nov 30, 2019 | -72.32% |
| Aug 31, 2019 | -94.30% |
| May 31, 2019 | -49.70% |
| Feb 28, 2019 | -7.08% |
| Nov 30, 2018 | -54.48% |